Constellation Pharmaceuticals
Cambridge, US
Biotech
Founders & leadership
TA
Tom A. ManiatisDirector
MR
Michael R. CooperExecutive Officer
AE
Anthony EvninDirector
JE
James E. AudiaExecutive Officer
KD
Keith DionneExecutive Officer, Director
ME
Matthias E. JaffeExecutive Officer
MA
Mark A. GoldsmithDirector
RA
Robert A. TepperDirector
DA
David A. GoeddelDirector
Reported raises · per SEC filings
Form D private placements$65MraisedOct 2019 · 11 investors · Biotechnology
Rule 506(b)$99MraisedApr 2018 · 30 investors · Biotechnology
Rule 506(b)$24.3MraisedSep 2016 · 17 investors · Biotechnology
Rule 506(b)$55.8MraisedDec 2015 · 22 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.